ITA 2025Converter
Back to Search
ITA 1961 → ITA 2025PGBP

Section 35 Section 36

Expenditure on scientific research

RetainedHigh - Impacts R&D budgets of pharma and tech companies.

Quick Answer

Section 35 of the Income Tax Act, 1961 (Expenditure on scientific research) corresponds to Section 36 of the Income-tax Act, 2025, effective 1st April 2026. Status: Retained.

What changed for Section 35

Under the Income Tax Act, 1961, Section 35 governs expenditure on scientific research. Deductions for revenue and capital expenditure on scientific research related to business, and contributions to approved research institutions.

From 1st April 2026, the same subject sits at Section 36 of the Income-tax Act, 2025 — retained and renumbered as Section 36 of the Income-tax Act, 2025. Weighted deductions (e.g., 150%) have been entirely phased out. Deduction is now restricted to 100% of the actual expenditure.

For Section 35, the practical impact is rated High. Impacts R&D budgets of pharma and tech companies.

Old Law (ITA 1961)Ch: IV-D

Sec 35

Provision Summary

Deductions for revenue and capital expenditure on scientific research related to business, and contributions to approved research institutions.

New Law (ITA 2025)Ch: VI

Sec 36

Provision Summary

Weighted deductions (e.g., 150%) have been entirely phased out. Deduction is now restricted to 100% of the actual expenditure.

Key Changes & Highlights

  • Alignment with simplified tax regimes which do not support weighted artificial deductions.

Frequently Asked Questions

What is Section 35 of the Income Tax Act, 1961 about?

Section 35 of the Income Tax Act, 1961 covers expenditure on scientific research. Deductions for revenue and capital expenditure on scientific research related to business, and contributions to approved research institutions.

Which section replaces Section 35 in the Income-tax Act, 2025?

Section 35 of the Income Tax Act, 1961 maps to Section 36 of the Income-tax Act, 2025, effective 1st April 2026 (status: Retained). Weighted deductions (e.g., 150%) have been entirely phased out. Deduction is now restricted to 100% of the actual expenditure.

What is the impact of the change to Section 35 under the new tax code?

The transition impact for Section 35 is rated High. Impacts R&D budgets of pharma and tech companies.

What should I watch out for when Section 35 moves to the 2025 code?

Alignment with simplified tax regimes which do not support weighted artificial deductions. These points are specific to Section 35 (Expenditure on scientific research).

Disclaimer: This mapping of Section 35 (Expenditure on scientific research) to Section 36 of the Income-tax Act, 2025 is for educational and reference purposes only, based on publicly available drafts and circulars. As Section 35 is currently marked Retained, always confirm its treatment with a qualified Chartered Accountant before filing or making compliance decisions.

Need professional help on Section 35?

Compare trusted providers — both offer CA services ready for the Income-tax Act, 2025.

*Affiliate links — we may earn a small commission at no extra cost to you. Disclosure.

Want to calculate tax on this section?

40+ free, browser-only tax tools at TaxNexus Pro →

Explore Tools